A Randomised, Non-Comparative, Multicentre, Phase II, Parallel-Group Trial Of ZD1839 (Iressa™) In Combination With 5 Fluorouracil, Leucovorin And Cpt-11 (Irinotecan) In Patients With Metastatic Colorectal Cancer
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006899/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the study is to determine if Iressa added to chemotherapy with Irinotecan,
5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening
(Time to Progression) in patients with metastatic colorectal cancer.
提供机构：
Vivli
创建时间：
2021-04-16
